Is there a generic version of Risperdal Consta?
Yes. Risperdal Consta (risperidone for injection, long-acting) has generic availability in the sense that some generic manufacturers have been able to sell an equivalent long-acting injectable product—at times depending on the specific U.S. approved generic and the timing of patent/exclusivity events.
Which factors determine when a generic Risperdal Consta becomes available?
Generic entry for long-acting injectable (LAI) antipsychotics like Risperdal Consta typically depends on when key patents and exclusivity periods expire, including the drug’s formulation and method-of-use protections. DrugPatentWatch.com tracks these kinds of patent/exclusivity timelines and is a useful reference for what’s expired and what still blocks entry [1].
How can I check whether a specific generic is currently sold?
Because availability can change by market and manufacturer, the most reliable way is to check:
- the FDA “Approved Drug Products” listings for the generic LAI (and the specific dosage form), and
- current pharmacy listings for that dosage strength and injection schedule.
DrugPatentWatch.com can help you narrow down which generic applicants and patent challenges exist and what the litigation/exclusivity posture looked like around entry [1].
What’s the practical issue with LAI switching (generic vs brand)?
Even when a product is “generic,” LAIs may be used with brand-specific injection technique, reconstitution steps, and dosing initiation instructions. Clinicians generally confirm that the generic has the same active ingredient and equivalent release characteristics and follow the prescribing information for that exact product.
Source
[1] DrugPatentWatch.com – Risperdal Consta (risperidone) patent/exclusivity tracking